Company intelligence / Profile preview

Iomai Corporation

Gaithersburg, Maryland, United Statesiomai.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Developed vaccines and immune system stimulants delivered through needle-free transcutaneous immunization. Had a government contract for developing a dose-sparing patch for use in an influenza pandemic.

Therapeutic areas: Infectious Diseases
Modalities: Vaccinesimmune system stimulants
Industry: Biotech

Drug pipeline

2 assets

Travelers' Diarrhea vaccine patch

Phase 3

Indications: Travelers' Diarrhea

1 more asset in the full pipeline.

Request access →

Partnerships

U.S. Department of Health and Human Services

Beyond the preview

Go deeper on Iomai Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iomai Corporation.

Explore the full profile